Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

Condition:   COVID19 Intervention:   Biological: Recombinant SARS-CoV-2 Fusion Protein Vaccine Sponsors:   Livzon Pharmaceutical Group Inc.;   Guangdong Center for Disease Prevention and Control;   Simoon Record Pharma Information Consulting Co., Ltd. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials